XML 27 R19.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings Per Share
6 Months Ended
Mar. 27, 2020
Earnings Per Share [Abstract]  
Earnings Per Share EARNINGS (LOSS) PER SHARE:
Basic earnings (loss) per share is computed using the weighted average number of common shares outstanding during the periods presented. Diluted earnings (loss) per share is computed using the weighted average number of common shares outstanding adjusted to include the potentially dilutive effect of stock awards.
The following table sets forth the computation of basic and diluted earnings (loss) per share attributable to the Company's stockholders (in thousands, except per share data):
Three Months EndedSix Months Ended
March 27, 2020March 29, 2019March 27, 2020March 29, 2019
Earnings (Loss):
Net (loss) income attributable to Aramark stockholders
$(202,260) $29,353  $(56,499) $280,037  
Shares:
Basic weighted-average shares outstanding
252,354  246,217  250,543  246,540  
Effect of dilutive securities(1)
—  4,130  —  4,815  
Diluted weighted-average shares outstanding
252,354  250,347  250,543  251,355  
Basic (Loss) Earnings Per Share:
Net (loss) income attributable to Aramark stockholders
$(0.80) $0.12  $(0.23) $1.14  
Diluted (Loss) Earnings Per Share:
Net (loss) income attributable to Aramark stockholders
$(0.80) $0.12  $(0.23) $1.11  

(1)
Incremental shares of 2.1 million and 3.8 million have been excluded from the computation of diluted weighted-average shares outstanding for the three and six months ended March 27, 2020, respectively, because the effect would have been antidilutive due to the net loss attributable to Aramark stockholders during both periods.
Share-based awards to purchase 5.0 million and 8.6 million shares were outstanding for the three months ended March 27, 2020 and March 29, 2019, respectively, but were not included in the computation of diluted earnings per common share, as their effect would have been antidilutive. In addition, PSUs related to 1.7 million shares were outstanding for both the three months ended March 27, 2020 and March 29, 2019, but were not included in the computation of diluted earnings per common share, as the performance targets were not yet met.
Share-based awards to purchase 4.1 million and 7.2 million shares were outstanding for the six months ended March 27, 2020 and March 29, 2019, respectively, but were not included in the computation of diluted earnings per common share, as their effect would have been antidilutive. In addition, PSUs related to 1.7 million shares were outstanding for both the six months ended March 27, 2020 and March 29, 2019, but were not included in the computation of diluted earnings per common share, as the performance targets were not yet met.